# C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes

> **NCT04005261** · — · COMPLETED · sponsor: **Goztepe Training and Research Hospital** · enrollment: 249 (actual)

## Conditions studied

- Type 2 Diabetes Treated With Insulin

## Interventions

- **DIAGNOSTIC_TEST:** C-peptide concentrations

## Key facts

- **NCT ID:** NCT04005261
- **Lead sponsor:** Goztepe Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2019-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04005261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04005261, "C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04005261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*